MoneyWorks4Me

Aarti Pharmalabs submits board meeting intimation

04 May 2024 Evaluate
Aarti Pharmalabs has informed that the meeting of the Board of Directors of the Company is scheduled on 13/05/2024, to consider and approve Audited Financial Results for the quarter ended March 31, 2024; Audited Financial Statements for the year ended March 31, 2024; Recommend Final Dividend, if any, for the year ended March 31, 2024; Approve any other business matter, if required, with the permission of Chair. 

The above information is a part of company’s filings submitted to BSE.

Aarti Pharmalabs Share Price

870.85 -15.60 (-1.76%)
13-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1942.85
Dr. Reddys Labs. 1206.00
Cipla 1461.00
Lupin 2261.00
Zydus Lifesciences 1173.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: